✦ LIBER ✦

Ease of use of rivastigmine patch can help manage medication for caregivers and patients with Alzheimer's disease

✍ Scribed by Riepe, M.; Weinman, J.; Brady, R.; Strohmaier, C.; Mueller, B.

Book ID: 123287201
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 82 KB
Volume: 333
Category: Article
ISSN: 0022-510X
DOI: 10.1016/j.jns.2013.07.1251

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

From high doses of oral rivastigmine to

From high doses of oral rivastigmine to transdermal rivastigmine patches: user experience and satisfaction among caregivers of patients with mild to moderate Alzheimer disease

✍ Reñé, R.; Ricart, J.; Hernández, B. 📂 Article 📅 2014 🏛 Elsevier 🌐 English ⚖ 719 KB

An open-labeled, multicentered, observat

An open-labeled, multicentered, observational study for the tolerability of Rivastigmine Transdermal Patch for Korean patients with Alzheimer's disease

✍ Hae Ri Na; Sangyun Kim; Dong-Won Yang; Moon Ho Park; Sang Seok Kim; Jung Seok Le 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 42 KB

Pharmacokinetics and Pharmacodynamics of

Pharmacokinetics and Pharmacodynamics of the Novel Daily Rivastigmine Transdermal Patch Compared With Twice-daily Capsules in Alzheimer's Disease Patients

✍ Lefèvre, G; Sędek, G; Jhee, S S; Leibowitz, M T; Huang, H-La; Enz, A; Maton, S; 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 172 KB

P1-377 Safety, tolerability, and caregiv

P1-377 Safety, tolerability, and caregiver's impressions of combination therapy with rivastigmine and memantine for the treatment of Alzheimer's disease

✍ Joshua R. Shuan-Haim; Mark D. Pass; Suhas Patel; Sameer Patel; Paul Lee; Juanita 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 167 KB

Long-Term Effects of Rivastigmine Treatm

Long-Term Effects of Rivastigmine Treatment on the Need for Psychotropic Medications in Nursing Home Patients with Alzheimer’s Disease

✍ Keith Edwards, Barbara Koumaras, Michael Chen, Ibrahim Gunay, Dr Dario Mirski 📂 Article 📅 2005 🏛 Springer International Publishing AG 🌐 English ⚖ 115 KB

Assessing the cost-effectiveness of the

Assessing the cost-effectiveness of the rivastigmine transdermal patch for Alzheimer's disease in the UK using MMSE- and ADL-based models

✍ Balázs Nagy; Alan Brennan; Ágnes Brandtmüller; Simu K. Thomas; Sean D. Sullivan; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 205 KB 👁 2 views

Assess long-term cost-effectiveness of rivastigmine patch in Alzheimer's disease (AD) management in the UK, using cognitive and functional models based on clinical trial efficacy data. Methods: Incremental costs and Quality Adjusted Life Years (QALYs) associated with rivastigmine patch and capsule t